Drug
Dexamethasone Intravitreal Implant clinical trials
- studies test it
- 34
- open now
- 2
- in phase 3
- 5
- first study started
- 2010
Keep track of what changes. Save the Dexamethasone Intravitreal Implant studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
34 studies that test it; most in 2011 (9)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 5
- Phase 4
- 14
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 29
Allergan (5) · Post Graduate Institute of Medical Education and Research, Chandigarh (3) · JHSPH Center for Clinical Trials (2) · Retina Macula Institute (2) · Ivana K. Kim (1) · Bay Area Retina Associates (1) · Texas Retina Associates (1) · Lions Eye Institute, Perth, Western Australia (1)
Often tested with
Tested in the same studies.
Dexamethasone (18) · Ranibizumab (4) · Bevacizumab (3) · Methotrexate (1) · Triamcinolone Acetonide (1) · Triamcinolone (1)
Studies
Open first, then newest update. How each study uses Dexamethasone Intravitreal Implant is read from its arms, and is right about nine times in ten.
Testing it · 34
- Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled TrialRecruitingPhase 4Tianjin Medical University Eye HospitalNCT05990829Written as Ozurdex
- Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During OperationRecruitingPhase 3Affiliated Hospital of Nantong UniversityNCT05138029Written as Dexamethasone intravitreal implant
- Dexamethasone Implant for Retinal Detachment in Uveal MelanomaCompletedPhase 1Ivana K. KimNCT04082962Written as Dexamethasone intravitreal implant
- Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to PhacoemulsificationCompletedPhase 4Bay Area Retina AssociatesNCT03832179Written as Ozurdex
- Ozurdex Monotherapy TrialWithdrawnPhase 4Ottawa Hospital Research InstituteNCT05101928Written as Ozurdex 0.7mg Ophthalmic Implant
- One Year Trial Evaluating Safety of Ozurdex With EyleaCompletedPhase 4Texas Retina AssociatesNCT03984110Written as Ozurdex
- Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialCompletedPhase 3JHSPH Center for Clinical TrialsNCT02623426Written as Dexamethasone intravitreal implant 0.7 mg
- Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in ChinaCompletedPhase 4AllerganNCT03908307Written as OZURDEX
- A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never TreatedCompletedPhase 4AllerganNCT03953807Written as Dexamethasone Intravitreal Implant
- Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaCompletedPhase 2Retina Macula InstituteNCT01571232Written as dexamethasone intravitreal implant
- Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMOCompletedPhase 4Lions Eye Institute, Perth, Western AustraliaNCT04619303Written as Dexamethasone intravitreal implant
- Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal MelanomaTerminatedPhase 2Arman MashayekhiNCT01471054Written as Ozurdex
- Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedPhase 4AllerganNCT01427751Written as dexamethasone intravitreal implant
- Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular EdemaCompletedPhase 2AllerganNCT01492400Written as dexamethasone Intravitreal Implant
- Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular EdemaCompletedPhase 4California Retina ConsultantsNCT02471651Written as Dexamethasone intravitreal implant (0.7 mg)
- PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema TrialCompletedPhase 3JHSPH Center for Clinical TrialsNCT02374060Written as Dexamethasone intravitreal implant
- Phase II Combination Steroid and Anti-VEGF for Persistent DMECompletedPhase 2Jaeb Center for Health ResearchNCT01945866Written as dexamethasone intravitreal implant
- Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)CompletedPhase 4The Cleveland ClinicNCT01613716Written as Ozurdex
- OZURDEX in Age Related Macular Degeneration as Adjunct to RanibizumabCompletedPhase 2McMaster UniversityNCT01243086Written as OZURDEX
- Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)CompletedNot applicableLong Island Vitreoretinal ConsultantsNCT01231633Written as Ozurdex
See all 34 studies that test Dexamethasone Intravitreal Implant →
Given in every arm · 2 — Dexamethasone Intravitreal Implant is usual care beside what is tested
- Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular EdemaWithdrawnPhase 2Pradeepa YoganathanNCT03629210Written as OZURDEX
- Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular EdemaTerminatedPhase 4North Toronto Eye Care Laser and Eye SpecialistsNCT02684084Written as Ozurdex
As the comparator · 3 — what is tested is compared with Dexamethasone Intravitreal Implant
- Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular OedemaRecruitingPhase 4Centre Hospitalier Universitaire DijonNCT04910503Written as Dexamethasone intravitreal implant
- EC-104 Intravitreal Implant for the Treatment of Diabetic Macular EdemaActive, not recruitingPhase 1/2Eclipse Life Sciences, Inc.NCT06536491Written as Dexamethasone intravitreal implant
- Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)CompletedPhase 1/2AllerganNCT01027650Written as dexamethasone intravitreal implant